The Patent Finder

Dompé Farmaceutici S.P.A.

42 patents currently held · Updated Nov 17, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 4 name spellings.

12
Ending by 2030
Nov 2026
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 30, 2026
    The maintenance fee for IL-8 inhibitors for use in the treatment of some sarcomas (US 11,660,291) comes due Nov 30, 2026. Unpaid by Jun 1, 2027, it lapses early.
  • 1 fee due Jun 17, 2027
    The maintenance fee for Sulfonamides as GPR40- and GPR120-Agonists (US 10,508,090) comes due Jun 17, 2027. Unpaid by Dec 17, 2027, it lapses early.
  • 1 fee due Sep 5, 2027
    The maintenance fee for Triglyceride Otic Formulations and Uses Thereof (US 11,918,653) comes due Sep 5, 2027. Unpaid by Mar 6, 2028, it lapses early.
  • 1 fee due Oct 30, 2027
    The maintenance fee for Auris Formulations for Treating Otic Diseases and Conditions (US 11,969,501) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 19, 2026
  • 1 term has ended since Aug 19, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,026,367(R)-arylalkylamino derivatives and pharmaceutical compositions containing them
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,039,6562-phenylpropionic acid derivatives and pharmaceutical compositions containing them
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,652,169(2R)-2-[(4-sulfonyl) aminophenyl] propanamides and pharmaceutical compositions containing them
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,868,046(2R)-2-[(4-sulfonyl) aminophenyl] propanamides and pharmaceutical compositions containing them
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,440,7112-aryl-2-fluoropropanoic acids and derivatives and pharmaceutical compositions containing them
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,133,911(R)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,751,281Auris Formulations for Treating Otic Diseases and Conditions
In force
 · High confidence
In forceHigh confidence
US 11,123,285Auris Formulations for Treating Otic Diseases and Conditions
In force
 · High confidence
In forceHigh confidence
US 11,969,501Auris Formulations for Treating Otic Diseases and Conditions
In force
 · High confidence
In forceHigh confidence
US 12,788,714Auris Formulations for Treating Otic Diseases and Conditions
In force
 · High confidence
In forceHigh confidence
10 of 42 patents shown.
Pro members see all 42.
Pro members: see all 42 patents
Also on record, not counted in the 42: 16 lapsed for an unpaid fee · 37 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

23 pending · 1 abandoned · 7 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited